Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice (vol 34, pg 563, 2015)

Bykerk Vivian P.; Oestoer Andrew J. K.; Alvaro-Gracia Jose; Pavelka Karel; Roman Ivorra Jose Andres; Graninger Winfried; Bensen William; Nurmohamed Michael T.; Krause Andreas; Bernasconi Corrado; Aassi Maher; Sibilia Jean

首页> 外文期刊>Clinical rheumatology >Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice (vol 34, pg 563, 2015)

【24h】

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice (vol 34, pg 563, 2015)

机译：类风湿关节炎患者对单一药物或与增效的抗风湿药联合使用托珠单抗的比较，以及对既往治疗的反应不足：接近临床实践的开放标签研究（第34卷，第563页，2015年）

获取原文

获取原文并翻译 | 示例

开具论文收录证明 >>

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Clinical rheumatology》 |2015年第7期|共1页
作者
Bykerk Vivian P.; Oestoer Andrew J. K.; Alvaro-Gracia Jose; Pavelka Karel; Roman Ivorra Jose Andres; Graninger Winfried; Bensen William; Nurmohamed Michael T.; Krause Andreas; Bernasconi Corrado; Aassi Maher; Sibilia Jean;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice (vol 34, pg 563, 2015) [J] . Bykerk Vivian P., Oestoer Andrew J. K., Alvaro-Gracia Jose, Clinical rheumatology . 2015,第7期

机译：类风湿关节炎患者对单一药物或与增效的抗风湿药联合使用托珠单抗的比较，以及对既往治疗的反应不足：接近临床实践的开放标签研究（第34卷，第563页，2015年）
2. Safety and efficacy of tocilizumab as monotherapy or in combination with methotrexate in Tunisian patients with active rheumatoid arthritis and inadequate response to disease-modifying anti-rheumatic drugs in conditions close to clinical practice [J] . Clinical rheumatology . 2020,第5期

机译：Tocilizumab作为单药治疗或与突尼斯患者中甲氨蝶呤组合的安全性和有效性，具有活跃的类风湿性关节炎，在接近临床实践的条件下对疾病改性抗风湿药物的反应不足
3. Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study. [J] . Yazici Y, Curtis JR, Ince A, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2012,第2期

机译：ROSE研究显示，tocilizumab在中度至重度活动性类风湿关节炎以及先前对疾病改变性抗风湿药反应不足的患者中的疗效。
4. Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice [O] . Vivian P. Bykerk, Andrew J. K. Östör, José Alvaro-Gracia, -1

机译：类风湿性关节炎患者对单独使用托珠单抗或与改变疾病的抗风湿药物联合使用以及对既往治疗反应不足的比较：一项接近临床实践的开放性研究
5. Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice [O] . Vivian P. Bykerk, Andrew J. K. Östör, José Alvaro-Gracia, 2015

机译：类风湿性关节炎患者对单独使用托珠单抗或与改变疾病的抗风湿药物联合使用以及对既往治疗反应不足的比较：一项接近临床实践的开放性研究

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice (vol 34, pg 563, 2015)

著录项

引文网络

相似文献

相关主题

期刊订阅